The USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program supports low- and middle-income countries to strengthen their pharmaceutical systems by strengthening pharmaceutical sector governance; increasing institutional and human resource capacity for pharmaceutical management and services, including regulation of medical products; increasing the availability and use of pharmaceutical information for decision-making and advancing the global learning agenda; optimizing pharmaceutical-sector financing, including resource allocation and use; and improving pharmaceutical services, including product availability and patient-centered care, to achieve health outcomes.
Health Technology Assessment (HTA) is a multidisciplinary process to determine the value of a health technology to inform healthcare resource allocation and decision-making. HTA is increasingly being adopted across various countries to support evidence-informed decisions for sustainable Universal Health Coverage (UHC). The US Agency for International Development (USAID) has provided funding under the Management Sciences for Health (MSH)-led MTaPS program to Indonesia in advancing HTA and achieving sustainable UHC. In 2013, the Presidential Regulation No. 12 on Health Insurance stipulated that to guarantee quality and cost control, the Ministry of Health (MOH) is responsible for conducting a health technology assessment (HTA). This led to the establishment of the Indonesian Health Technology Assessment Committee (InaHTAC) housed within the Indonesian Health Financing and Insurance Center (PPJK). InaHTAC is responsible for providing health policy recommendations to the minister regarding health technologies covered under the National Health Insurance scheme, JKN. The committee has completed and provided recommendations for 12 health technologies since 2014 in partnership with six Indonesian universities. Under the activities described in this scope, MTaPS will work with government officials and academics in Indonesia to strengthen HTA strategy and processes that increase HTA efficiency and effectiveness in the country.
Services to be provided
In collaboration with the USAID Asia Bureau, USAID Indonesia Mission, and MTaPS headquarters teams, a senior consultant in Indonesia will support the assessment and revision of the current HTA topic selection process of the InaHTAC. This will consist on the following activities:
- Defining policy questions and objectives
The consultant will virtually convene experts from the relevant directorates of MOH including PPJK, the MOH Pharmaceuticals Directorate (Farmalkes), the National Public Procurement Agency (LKPP), the National Health Insurance Agency (BPJS-K), and other relevant agencies to define the key policy questions and objectives redesigning the topic selection process. This exercise will define the Government of Indonesia (GOI) priorities, the type of interconnectivity sought within the system, stakeholders that need to be engaged in the process, and areas where processes are duplicated and fragmented but can be streamlined.
- Stakeholder analysis, desk review, and key informant interviews
Once the key objectives are defined, the consultant will support a desk review of literature and documentation related to HTA in Indonesia and global best practices related to topic selection. The senior consultant will conduct a stakeholder analysis to identify relevant stakeholders for key informant interviews. He/She will conduct key informant interviews to gather any information on stakeholder roles, incentives, priorities, and perspectives. The final number and mode (in-person versus remote) will be determined based on the desk review and discussions with the HTA committee secretariat and PPJK. Potential stakeholders may include representatives from BPOM, the national procurement agency (LKPP), PPJK, BPJSK, MOH, Formularium Nasional (ForNas), academia, and patient groups as well as clinicians, etc.
The services provided through this consultancy will help to strengthen the topic selection process for the HTA committee (InaHTAC) in Indonesia and the production of related deliverables.
The consultant should have the following qualifications:
- Master’s degree or PhD in health economics, health financing, or equivalent.
- Minimum of 10 years of relevant work experience in the Indonesia health system.
- Experience in designing, teaching or leading training of public health researchers and policy makers.
- Experience working with or collaborating with the Ministry of Health in Indonesia with strong knowledge of the health financing system in the public and private sector.
- Experience working with a leading academic institution, the PPJK or National Health Insurance
- Agency (BPJS-K) is an asset.
- Oral and written fluency in English and Bahasa is required.
- Advanced skills in MS Excel is required.
- Ability to organize the own work with minimum supervision.
- Ability to write and prepare reports, training materials, documents and presentations.
- The person must currently reside in Indonesia.
How to Apply
To apply, please use this link: